Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

ClinicalTrials.gov ID: NCT00000774

Public ClinicalTrials.gov record NCT00000774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 23, 2026, 10:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

PRIMARY: To determine the safety of envelope recombinant proteins rgp120/HIV-1MN (Genentech) and rgp120/HIV-1SF2 (Chiron/Biocine) in infants who are of indeterminate HIV status born to HIV-infected women. To evaluate changes in viral load in infants proven to be infected and absolute CD4 counts in all immunized infants. SECONDARY: To evaluate the immunogenicity of these envelope recombinant proteins in infants of indeterminate HIV status born to HIV-infected women. Only 30-50 percent of HIV-infected infants have detectable virus at birth. Successful early sensitization to HIV envelope epitopes may help prevent infection or, alternatively, may enhance HIV-specific immune function to alter HIV replication and disease progression.

Study identification

NCT ID
NCT00000774
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
156 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Day to 3 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Dec 31, 1998
Last update posted
Nov 3, 2021

Ends 1999

United States locations

U.S. sites
36
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach California 90801
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California 900951752
UCSD Maternal, Child, and Adolescent HIV CRS San Diego California 920930672
San Francisco Gen. Hosp. San Francisco California 94110
UCSF Pediatric AIDS CRS San Francisco California 941430105
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance California 905022004
Univ. of Colorado Denver NICHD CRS Aurora Colorado 802181088
Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease New Haven Connecticut 06504
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161
Cook County Hosp. Chicago Illinois 60612
Chicago Children's CRS Chicago Illinois 606143394
Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago Illinois 606371470
Tulane Univ. Health Science Ctr., Tulane Univ. Hosp. & Clinic New Orleans Louisiana 701122699
Tulane/LSU Maternal/Child CRS New Orleans Louisiana
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases Baltimore Maryland 212874933
Brigham and Women's Hosp., Div. of Infectious Disease Boston Massachusetts 02115
BMC, Div. of Ped Infectious Diseases Boston Massachusetts 02118
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts
Baystate Health, Baystate Med. Ctr. Springfield Massachusetts 01199
NJ Med. School CRS Newark New Jersey 07103
St. Joseph's Hosp. & Med. Ctr. of New Jersey Paterson New Jersey
NYU Med. Ctr., Dept. of Medicine New York New York 10016
Columbia IMPAACT CRS New York New York 10032
Incarnation Children's Ctr. New York New York 10032
Strong Memorial Hospital Rochester NY NICHD CRS Rochester New York 14642
Univ. of Rochester ACTG CRS Rochester New York
SUNY Stony Brook NICHD CRS Stony Brook New York 117948111
SUNY Upstate Med. Univ., Dept. of Peds. Syracuse New York 13210
Bronx-Lebanon Hosp. IMPAACT CRS The Bronx New York 10457
WNE Maternal Pediatric Adolescent AIDS CRS Worcester New York
DUMC Ped. CRS Durham North Carolina 277103499
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania 191044318
Univ. of Pennsylvania Health System, Hosp. of the Univ. of Pennsylvania Philadelphia Pennsylvania 19104
Texas Children's Hosp. CRS Houston Texas 77030
UW School of Medicine - CHRMC Seattle Washington 981050371

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Sep 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →